Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ defibrillation lead. Now ...
Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals; Far-Field Sensing and ...
A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...
Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for ...
Israel's Prime Minister Benjamin Netanyahu was rushed to the Sheba Medical Center where early Sunday morning he had a cardiac pacemaker implanted. (Photo by JACK GUEZ/AFP via Getty Images) When you ...
A made-in-Calgary 4D heart model is transforming treatment for heart failure patients having a specialized pacemaker inserted, called cardiac resynchronization therapy (CRT). In a clinical trial, ...
The cardiac pacemaker harmlessly dissolves over the course of 35 days. (Courtesy: Northwestern University) Temporary cardiac pacemakers provide essential pacing for patients with short-term heart ...
Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...
The rhythm is regular at a rate of 78 beats/min. Before each QRS complex, there are two pacing stimuli (+,v) with a very short interval (0.06 sec) between them. They are both ventricular pacing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results